Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Bacil Pharma: Board Meeting Intimation for 1) To Consider And Approve The Un-Audited Financial Results Along With Limited Review Report Of The Company For The Quarter Ended 31St December 2024.2) Other Routine Business With The Permission Of The Chair.
News Announcement

Bacil Pharma: Board Meeting Intimation for 1) To Consider And Approve The Un-Audited Financial Results Along With Limited Review Report Of The Company For The Quarter Ended 31St December 2024.2) Other Routine Business With The Permission Of The Chair.

13-Jan-2025 Follow Value Research Online on Google download pdfDownload PDF Bacil Pharma

BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 inter alia to consider and approve 1) the Un-Audited Financial Results along with Limited Review Report of the Company for the Quarter ended 31st December 2024.2) Other routine business with the permission of the Chair.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds